RO — Roche Holding LtdHealthcare · Drug Manufacturers - GeneralSIX
CHF 34.5B
Mkt Cap
CHF 62.1B
Ent. Value
-CHF 27.6B
Net Cash
CHF 323.00
52W CHF 256 – CHF 383
CHF 34.5B
Mkt Cap
CHF 62.1B
Ent. Value
-CHF 27.6B
Net Cash
20.2×
P/E TTM
14.14
PEG
2.6×
P/FCF
1.0×
P/Book
0.5×
P/Sales
2.9×
EV/EBITDA
3.4×
EV/EBIT
4.7×
EV/FCF
1.0×
EV/Sales
5.0%
Earn Yld
5.1%
FCF Yld
3.0%
Div Yld
CHF 323.00
·
All values in Swiss Francs (CHF)
CHF
FY2025
FY2024
FY2023
FY2022
Revenue
63.36B
62.40B
60.44B
65.81B
YoY Growth
+1.5%
+3.2%
-8.2%
—
Gross Profit
46.71B
46.11B
44.08B
46.08B
Gross Margin
73.7%
73.9%
72.9%
70.0%
R&D
13.35B
15.30B
14.20B
15.22B
SG&A
15.16B
14.90B
14.88B
14.20B
EBIT
18.48B
13.42B
15.39B
17.48B
EBIT Margin
29.2%
21.5%
25.5%
26.6%
D&A
3.39B
3.42B
3.46B
3.84B
EBITDA
21.70B
16.62B
18.54B
20.86B
EBITDA Margin
34.3%
26.6%
30.7%
31.7%
Net Income
12.88B
8.28B
11.50B
12.42B
Net Margin
20.3%
13.3%
19.0%
18.9%
EPS (diluted)
CHF 16.04
CHF 10.31
CHF 14.31
CHF 15.37
Shares (dil., M)
803
802
804
808
Company Brief
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
